Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Working Capital Changes: 2015-2024

Historic Other Working Capital Changes for Outlook Therapeutics (OTLK) over the last 10 years, with Sep 2024 value amounting to $4.9 million.

  • Outlook Therapeutics' Other Working Capital Changes rose 109.03% to $986,834 in Q3 2020 from the same period last year, while for Sep 2020 it was $310,270, marking a year-over-year increase of 103.81%. This contributed to the annual value of $4.9 million for FY2024, which is 287.29% up from last year.
  • According to the latest figures from FY2024, Outlook Therapeutics' Other Working Capital Changes is $4.9 million, which was up 287.29% from -$2.6 million recorded in FY2023.
  • Over the past 5 years, Outlook Therapeutics' Other Working Capital Changes peaked at $4.9 million during FY2024, and registered a low of -$2.6 million during FY2023.
  • In the last 3 years, Outlook Therapeutics' Other Working Capital Changes had a median value of $3.1 million in 2022 and averaged $1.8 million.
  • As far as peak fluctuations go, Outlook Therapeutics' Other Working Capital Changes skyrocketed by 1,526.41% in 2020, and later slumped by 184.61% in 2023.
  • Over the past 5 years, Outlook Therapeutics' Other Working Capital Changes (Yearly) stood at $310,270 in 2020, then spiked by 457.56% to $1.7 million in 2021, then skyrocketed by 78.78% to $3.1 million in 2022, then plummeted by 184.61% to -$2.6 million in 2023, then soared by 287.29% to $4.9 million in 2024.